NTRK fusion in Japanese colorectal adenocarcinomas
Abstract NTRK fusion-positive tumors are known to be highly sensitive to TRK inhibitors, such as larotrectinib and entrectinib. Therefore, identification of patients who can potentially benefit from these inhibitors is important; however, the frequency of NTRK fusions in Japanese patients with color...
Guardado en:
Autores principales: | Yuya Yamashiro, Taisei Kurihara, Takuo Hayashi, Yoshiyuki Suehara, Takashi Yao, Shunsuke Kato, Tsuyoshi Saito |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d4b40b23678a4b69aaac2112c31e7373 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
por: Keita Sasa, et al.
Publicado: (2021) -
NTRK Gene Fusion Detection in Atypical Spitz Tumors
por: Rocco Cappellesso, et al.
Publicado: (2021) -
Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma
por: Simon Strohmeier, et al.
Publicado: (2021) -
Dermoscopic Features of Spitz Tumor With LMNA-NTRK1 Fusion
por: Ben J. Friedman, et al.
Publicado: (2020) -
Clinical and radiographic response following targeting of BCAN-NTRK1 fusion in glioneuronal tumor
por: Christopher Alvarez-Breckenridge, et al.
Publicado: (2017)